Health And Pharma
Health & Pharma. Health and Pharma is a new-generation international news and communication platform. Our goal is to collaborate with health science and pharma professionals to report directly from the news sources and strive to be recognized as a trusted news platform.
About Us - Health And Pharma
Health & Pharma. Health and Pharma is a new-generation international news and communication platform. Our goal is to collaborate with health science and pharma professionals to report directly from the news sources and strive to be recognized as a trusted news platform.
Health and Pharma | Health And Medicine
Health and Pharma is a new-generation international news and communication platform. We strive to be a top-tier trusted news outlet, delivering firsthand reports from reliable channels.
Posts | Health And Medicine
Dec 21, 2024 · Health & Pharma. Health and Pharma is a new-generation international news and communication platform. Our goal is to collaborate with health science and pharma professionals to report directly from the news sources and strive to be recognized as a trusted news platform.
Posts | Health And Medicine
The OVATION 2 Study and the Novel Immunotherapy IMNN-001 for Ovarian Cancer. ONCOLife | 12 September 2024
Posts | Health And Medicine
Nimbus Reports Early Success in Treating Solid Tumors with NDI-101150, an HPK1 Inhibitor. Clinical Trials | 24 May 2024
Olaparib Shows Long-term Survival Benefits in BRCA+ and HER2
Dec 13, 2024 · A Transformative Option in Early-Stage Disease. When first announced in 2022, the OlympiA findings led to regulatory approval of olaparib in the adjuvant (post-surgery) setting for certain patients with HER2-negative, BRCA-positive breast cancer.
Posts | Health And Medicine
BioTrace: First FDA-Cleared Ultrasound Software for Liver Tumor Response Prediction. Medical Devices | 10 January 2024
How AI is Shaping Drug Discovery: LP-300 in Lung Cancer Treatment
Nov 27, 2024 · Could you explain how LP-300's mechanism of action interacts with tyrosine kinase inhibitors and affects cancer cells in never smokers? Dr. Reggie Ewesuedo: LP-300 has been under development for some time, initially with a recognized mechanism of action unrelated to its effects on tyrosine kinase receptors.It’s known to resensitize tumor cells to chemotherapeutic agents by resetting the ...
Contact Us - Health And Pharma
For General Inquiries: Email: info@healthandpharma.net Telephone: +1 315 215 1087